Unprecedented efforts are driving the global push for a safe and effective vaccine. If and when we have one (or more), here’s how it’s likely to be rolled out in Australia.
Articles on COVAX
Displaying 41 - 46 of 46 articles
Side agreements signed by some wealthy nations threaten to undercut global efforts to ensure a fairly equitable worldwide vaccination effort.
The Trump administration wants to go it alone when it comes to vaccine development and distribution. What does this mean for the U.S. and the world?
With $1 billion in advance purchase agreements for COVID-19 vaccines, Canada has joined the vaccine nationalists: rich countries buying up more than half the global short-term supply of vaccine.
Australia’s contribution to the global COVAX initiative helps secure future vaccines. Here’s the full field of candidates.
More than 170 countries have signed up to the Global Access (COVAX) initiative, but vaccine hoarding has already begun by many wealthy countries — leaving poorer nations potentially in the lurch.
Top contributors
-
Professor of Public Health, La Trobe University
-
Executive Director, African Population and Health Research Center
-
Professor and Distinguished Research Chair, Globalization and Health Equity, L’Université d’Ottawa/University of Ottawa
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Associate Principal Research Fellow, Burnet Institute
-
Senior Scholar with the Global Health Policy & Politics Initiative at the O’Neill Institute, Georgetown University
-
Professor of Philosophy, Binghamton University, State University of New York
-
Reader, Global Development Institute, University of Manchester
-
Professor of International Politics, Queen Mary University of London
-
Part-time lecturer at the Global Health & Social Medicine, Harvard University, and Lecturer at the School of Public Health, College of Health Sciences, University of Liberia
-
Clinical associate professor, Faculty of Medicine, University of British Columbia
-
Sarah Joseph is a Friend of The Conversation.
Professor of Human Rights Law, Griffith University
-
Senior Researcher, Health Economics, University of Oxford
-
Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, University of the Witwatersrand
-
Assistant Professor of Global Health and Social Medicine, Harvard University